Pulmatrix, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Pulmatrix, Inc. (NASDAQ: PULM) on April 21, 2026, covering events occurring on April 16, 2026. The filing reports the closing of a previously announced private placement of Series B Preferred Stock.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on the corporate action of the private placement closing.
Material Changes
- Capital Raise: On April 16, 2026, the Company closed a private placement of Series B Preferred Stock (par value $0.0001 per share).
- Regulatory Status: The transaction was exempt from registration under Section 4(a)(2) of the Securities Act and Rule 506 of Regulation D.
- Leadership: The report was signed by Peter Ludlum, identified as Interim Chief Executive Officer and Interim Chief Financial Officer.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future operations, or specific risk factors beyond the standard regulatory disclosures. The information is furnished pursuant to Item 7.01 (Regulation FD Disclosure) and Item 8.01 (Other Events) and is not deemed filed for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Verify the total number of Series B Preferred Stock shares issued and the purchase price per share in the accompanying press release (Exhibit 99.1).
- Confirm the identity of the investors participating in the private placement.
- Review the terms of the Series B Preferred Stock, including dividend rights, liquidation preferences, and conversion features.
- Assess the impact of the new equity issuance on existing shareholder dilution.